Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Blood Advances Community Conversations - The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles

The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles

06/02/18 • 10 min

Blood Advances Community Conversations

The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles by Blood Advances Community Conversations

plus icon
bookmark

The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles by Blood Advances Community Conversations

Previous Episode

undefined - Misdiagnosis of primary immune thrombocytopenia

Misdiagnosis of primary immune thrombocytopenia

Misdiagnosis of primary immune thrombocytopenia by Blood Advances Community Conversations

Next Episode

undefined - Chemotherapy use in AML

Chemotherapy use in AML

Chemotherapy use in AML by Blood Advances Community Conversations

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/blood-advances-community-conversations-96723/the-human-il-15-superagonist-alt-803-directs-siv-specific-cd8-t-cells-5150469"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the human il-15 superagonist alt-803 directs siv-specific cd8+ t cells into b-cell follicles on goodpods" style="width: 225px" /> </a>

Copy